Aarkstore - Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014

1
Aarkstore - Idiopathic Pulmonary Fibrosis -
Pipeline Review, H2 2014
www.aarkstore.com
2
Summary

• Idiopathic Pulmonary Fibrosis - Pipeline Review,
  H2 2014, provides an overview of
• the Idiopathic Pulmonary Fibrosiss therapeutic
  pipeline.
• This Market Research Report provides
  comprehensive information on the therapeutic
• development for Idiopathic Pulmonary Fibrosis,
  complete with comparative analysis at
• various stages, therapeutics assessment by drug
  target, mechanism of action (MoA), route of
• administration (RoA) and molecule type, along
  with latest updates, and featured news and
• press releases. It also reviews key players
  involved in the therapeutic development for
• Idiopathic Pulmonary Fibrosis and special
  features on late-stage and discontinued
  projects.

www.aarkstore.com
www.aarkstore.com
3
Scope

• - The report provides a snapshot of the
  global therapeutic landscape of Idiopathic
  Pulmonary Fibrosis- The report reviews key
  pipeline products under drug profile section
  which includes, product description, MoA and RD
  brief, licensing and collaboration details
  other developmental activities - The report
  reviews key players involved in the therapeutics
  development for Idiopathic Pulmonary Fibrosis and
  enlists all their major and minor projects- The
  report summarizes all the dormant and
  discontinued pipeline projects - A review of the
  Idiopathic Pulmonary Fibrosis products under
  development by companies and universities/research
  institutes based on information derived from
  company and industry-specific sources- Pipeline
  products coverage based on various stages of
  development ranging from pre-registration till
  discovery and undisclosed stages- A detailed
  assessment of monotherapy and combination therapy
  pipeline projects- Coverage of the Idiopathic
  Pulmonary Fibrosis pipeline on the basis of
  target, MoA, route of administration and molecule
  type

www.aarkstore.com
4
Reasons to buy

• - Provides strategically significant
  competitor information, analysis, and insights to
  formulate effective RD development strategies-
  Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive
  advantage- Develop strategic initiatives by
  understanding the focus areas of leading
  companies- Identify and understand important and
  diverse types of therapeutics under development
  for Idiopathic Pulmonary Fibrosis- Plan mergers
  and acquisitions effectively by identifying key
  players of the most promising pipeline- Devise
  corrective measures for pipeline projects by
  understanding Idiopathic Pulmonary Fibrosis
  pipeline depth and focus of Indication
  therapeutics- Develop and design in-licensing
  and out-licensing strategies by identifying
  prospective partners with the most attractive
  projects to enhance and expand business potential
  and Scope- Modify the therapeutic portfolio by
  identifying discontinued projects and
  understanding the factors that drove them from
  pipeline  

www.aarkstore.com
5
Table of Contents

• IntroductionREPORT COVERAGEIdiopathic
  Pulmonary Fibrosis OverviewTherapeutics
  DevelopmentPipeline Products for Idiopathic
  Pulmonary Fibrosis - OverviewPipeline Products
  for Idiopathic Pulmonary Fibrosis - Comparative
  AnalysisIdiopathic Pulmonary Fibrosis -
  Therapeutics under Development by
  CompaniesIdiopathic Pulmonary Fibrosis -
  Therapeutics under Investigation by
  Universities/InstitutesIdiopathic Pulmonary
  Fibrosis - Pipeline Products GlanceLate Stage
  ProductsClinical Stage ProductsEarly Stage
  Products

www.aarkstore.com
6
List Of Tables

• Number of Products under Development for
  Idiopathic Pulmonary Fibrosis, H2 2014Number of
  Products under Development for Idiopathic
  Pulmonary Fibrosis - Comparative Analysis, H2
  2014Number of Products under Development by
  Companies, H2 2014Number of Products under
  Development by Companies, H2 2014
  (Contd..1)Number of Products under Development
  by Companies, H2 2014 (Contd..2)Number of
  Products under Investigation by
  Universities/Institutes, H2 2014Comparative
  Analysis by Late Stage Development, H2
  2014Comparative Analysis by Clinical Stage
  Development, H2 2014Comparative Analysis by
  Early Stage Development, H2 2014Products under
  Development by Companies, H2 2014

www.aarkstore.com
7
List Of Figures

• Number of Products under Development for
  Idiopathic Pulmonary Fibrosis, H2 2014Number of
  Products under Development for Idiopathic
  Pulmonary Fibrosis - Comparative Analysis, H2
  2014Number of Products under Development by
  Companies, H2 2014Number of Products under
  Investigation by Universities/Institutes, H2
  2014Comparative Analysis by Clinical Stage
  Development, H2 2014Comparative Analysis by
  Early Stage Products, H2 2014Assessment by
  Monotherapy Products, H2 2014Number of Products
  by Top 10 Target, H2 2014Number of Products by
  Stage and Top 10 Target, H2 2014Number of
  Products by Top 10 Mechanism of Action, H2 2014

www.aarkstore.com
8
Related Market Research reports

• Corticosteroid-Responsive Dermatoses - Pipeline
  Review, H1 2014
• Hematological Tumor - Pipeline Review, H1 2014
• Inflammation - Pipeline Review, H1 2014
• Opioid Induced Side Effects - Pipeline Review, H1
  2014
• Skin Infections - Pipeline Review, H1 2014

www.aarkstore.com
9
Related Market Research reports

• Restenosis - Pipeline Review, H1 2014
• Tauopathies - Pipeline Review, H1 2014
• Nasopharyngitis (Common Cold) - Pipeline Review,
  H1 2014
• Mucopolysaccharidosis III (MPS III) (Sanfilippo
  Syndrome) - Pipeline Review, H1 2014
• Chemotherapy Induced Peripheral Neuropathy -
  Pipeline Review, H1 2014

www.aarkstore.com
10
Aarkstore - Idiopathic Pulmonary Fibrosis -
Pipeline Review, H2 2014
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us

• Office
• Office No. - 809, 8th Floor,
• B-Wing, Mahaavir Icon, 
• Plot No.- 89 90, Sector-15,
• CBD-Belapur, Navi Mumbai 400614, 
• Maharashtra, India.
• 24/7 Online Support 91 9987295242
• General Inquiries 91 - 22 2756 4953
• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog http//www.aarkstore.com/blog/
• Conference http//conference.aarkstore.com/
• News http//www.aarkstore.com/news

www.aarkstore.com